Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.
about
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Accelerated atherosclerosis in a human immunodeficiency virus infected patient not on highly active anti-retroviral therapy: An autopsy case report.Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events ofCardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population.Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australiaThe burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated servicesPopulation-based study of risk factors for coronary heart disease among HIV-infected personsRisk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals-a clinical cohort studyAssociation of C-reactive protein and HIV infection with acute myocardial infarction.Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.C-Reactive Protein as an Independent Cardiovascular Risk Predictor in HIV+ Patients: A Focused Review of Published Studies.Frequency of Subclinical Atherosclerosis in Brazilian HIV-Infected Patients.Risk of coronary heart disease among HIV-infected patients: a multicenter study in Brazil
P2860
Q27690715-2A930E28-C08B-4BCA-8618-AB57E6779596Q30410181-FE2B9B35-6415-4745-932A-75305453ABF1Q30987054-D4256F3E-9D4A-4A2D-BB44-561A540D0CEFQ35949949-D52FCE20-ED6C-47F6-9B73-0DE237DE4C8FQ35997703-8F1560E1-3A1F-40BC-9472-E9F822192E59Q36220892-4F9E9E6F-0FCA-47C8-9C1B-5981AF7892D3Q36291572-4D26180C-E2B1-463B-83D5-7172506723FFQ36497046-36065F8E-54BF-49DA-B3E9-F57361A05E7AQ37256483-AD4C3BFE-2737-43B2-8996-F69314A57755Q37390630-F8904E61-BEE4-4B6D-B361-1D5DCC4A1B3CQ37604527-1A4F3E04-BC6E-4583-B1D6-BBBF34434A5CQ38723259-70FEFCB6-ADC1-40BD-9ACF-B326219EE63EQ40098541-78B2C0FF-6A3B-4836-B7DC-DC3070A63F19Q42373024-C2B2C3BC-DED7-4353-B958-46A246387008Q55078006-D2BA9806-39A0-4B58-BD44-F4A7AC32C6AEQ59033147-4B629F4B-7AB5-4B43-89B7-A1A521D930A9
P2860
Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of appropriate cor ...... dels in HIV-infected patients.
@en
Development of appropriate cor ...... dels in HIV-infected patients.
@nl
type
label
Development of appropriate cor ...... dels in HIV-infected patients.
@en
Development of appropriate cor ...... dels in HIV-infected patients.
@nl
prefLabel
Development of appropriate cor ...... dels in HIV-infected patients.
@en
Development of appropriate cor ...... dels in HIV-infected patients.
@nl
P2093
P2860
P1433
P1476
Development of appropriate cor ...... odels in HIV-infected patients
@en
P2093
Kristin E Mondy
Linda R Peterson
Morris Schambelan
Peter W F Wilson
Ralph B D'Agostino
Sharon Nachman
Signe W Worm
Tarek A Helmy
Victor G Dávila-Román
W Todd Cade
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.189627
P407
P577
2008-06-19T00:00:00Z